Physician

Saligrama B Bhat, MD

According to 2025 Medicare claims, Saligrama Bhat, MD (NPI: 1639129182) practices pulmonary disease in the Punta Gorda, FL market, with the plurality of this provider's patient population coming from Charlotte, FL. This provider's primary affiliated billing organization is SALIGRAMA BHAT MD PA (NPI: 1942223342; TIN: 592569181) and primary practice location at 33952-5000.

Bhat's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 510 traditional Medicare patients, billed 9,227 HCPCS/CPT codes, and received $547,635 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,749 prescription claims across 198 beneficiaries totaling $153,283 in drug costs, led by Eliquis (Apixaban). DME data shows 821 claims. Open Payments data shows 37 records totaling $582. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $104,677 and ending at $38,329.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	609	17,622	$759,079
2016	813	16,011	$765,051
2017	721	16,310	$793,995
2018	590	14,707	$684,089
2019	575	14,229	$696,768
2020	496	14,024	$699,548
2021	441	12,827	$650,943
2022	511	12,342	$638,090
2023	465	9,932	$550,727
2024	510	9,227	$547,635

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	313	4,743	$328,698
2016	287	4,232	$303,542
2017	277	3,946	$369,592
2018	259	3,250	$308,594
2019	287	3,225	$284,961
2020	282	4,031	$382,595
2021	248	3,692	$417,814
2022	215	3,097	$352,553
2023	197	1,855	$254,107
2024	198	1,749	$153,283

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	682	1,871	$116,469
2016	608	1,555	$73,405
2017	587	1,496	$60,402
2018	530	1,334	$52,286
2019	445	1,203	$44,572
2020	515	1,335	$60,375
2021	425	1,272	$57,900
2022	381	1,013	$47,658
2023	322	817	$43,108
2024	274	821	$35,744

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	366	469	$134
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	154	609	$98
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	360	1,499	$91
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	263	1,230	$61
94640	Inhalation treatment for airway obstruction or sputum production	118	647	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	32	1,350	$25,840
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	35	1,230	$25,227
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	1,140	$23,393
Breo Ellipta	Fluticasone/Vilanterol	14	600	$7,645
Spiriva Respimat	Tiotropium Bromide	11	390	$7,222

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7031	Face mask interface, replacement for full face mask, each	N	28	78	$7,176
A7030	Full face mask used with positive airway pressure device, each	N	28	77	$6,415
E0601	Continuous positive airway pressure (cpap) device	Y	16	115	$3,376
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	34	85	$3,152
A7032	Cushion for use on nasal mask interface, replacement only, each	N	11	28	$2,781

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	37	$582	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Saligrama B. Bhat, MD?

Tedicare shows public-source Medicare data for Saligrama B. Bhat, MD (NPI 1639129182), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Saligrama B. Bhat, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Saligrama B. Bhat, MD?

Saligrama B. Bhat, MD is linked to SALIGRAMA BHAT MD PA (billing NPI 1942223342) in the available physician profile data.

Does Saligrama B. Bhat, MD have Open Payments data?

Saligrama B. Bhat, MD has 37 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.